Correlation Between Eledon Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Eledon Pharmaceuticals and Blueprint Medicines
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eledon and Blueprint is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Eledon Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 2.3 times more return on investment than Blueprint Medicines. However, Eledon Pharmaceuticals is 2.3 times more volatile than Blueprint Medicines Corp. It trades about 0.16 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.07 per unit of risk. If you would invest 172.00 in Eledon Pharmaceuticals on March 7, 2024 and sell it today you would earn a total of 115.00 from holding Eledon Pharmaceuticals or generate 66.86% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Eledon Pharmaceuticals vs. Blueprint Medicines Corp
Performance |
Timeline |
Eledon Pharmaceuticals |
Blueprint Medicines Corp |
Eledon Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eledon Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Eledon Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.Eledon Pharmaceuticals vs. Akari Therapeutics PLC | Eledon Pharmaceuticals vs. Artelo Biosciences | Eledon Pharmaceuticals vs. Nutriband | Eledon Pharmaceuticals vs. Aileron Therapeutics |
Blueprint Medicines vs. Akari Therapeutics PLC | Blueprint Medicines vs. Artelo Biosciences | Blueprint Medicines vs. Nutriband | Blueprint Medicines vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |